Evidence map›Paper›PMID 42453704›Full record

ArticleEuropean journal of radiology artificial intelligence2026

Complex Deep Neural Networks for Denoising Ultra-Fast Submillimeter T2*-weighted Imaging and Quantitative Susceptibility Mapping.

Bryan Quah, Sreekanth Madhusoodhanan Nair, Chang Gao, Michael Luu, Brian Renner, Jin Jin, Fei Han, Elaina Luskin, Arzu C Has Silemek, Nader Binesh and 10 more

Abstract read
In one paragraph

Article in European journal of radiology artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Bryan QuahNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sreekanth Madhusoodhanan NairNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Chang GaoSiemens Medical Solution USA Inc., Los Angeles, CA, USA.
Michael LuuBiostatistics Shared Resource, Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Brian RennerNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Jin JinSiemens Healthcare Pty Ltd, Brisbane, Australia.
Fei HanSiemens Medical Solution USA Inc., Los Angeles, CA, USA.
Elaina LuskinNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Arzu C Has SilemekNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Nader BineshDepartment of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Debiao LiBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Marwa KaiseyDepartment of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Daniel S ReichTranslation Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Nancy L SicotteDepartment of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Russell T ShinoharaDepartment of Biostatistics, Epidemiology, and Informatics, Penn Statistics in Imaging and Visualization Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Omar Al-LouziNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Xiuzhen HuangDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Marcel MayaDepartment of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Daniel OntanedaMellen Center, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH.
Pascal SatiNeuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Funding

Central Vein Sign: A Diagnostic Biomarker in Multiple SclerosisU01NS116776 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI ONTANEDA, DANIEL, SATI, PASCAL · 2020 to 2024
$7.1M
Inter-modal Coupling Image AnalyticsR01MH112847 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Theodore Satterthwaite, Russell Takeshi Shinohara · 2017 to 2026
$5.9M
Advanced Statistical Analytics of MRI in MSR01NS112274 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SHINOHARA, RUSSELL TAKESHI · 2020 to 2024
$2.8M
NIMH NIH HHS R01 MH112847NINDS NIH HHS R01 NS112274NINDS NIH HHS U01 NS116776
6 · The paper itself

Abstract

The 2024 revisions of the McDonald diagnostic criteria for multiple sclerosis (MS) have incorporated susceptibility-based magnetic resonance imaging (MRI) biomarkers to improve diagnostic sensitivity and specificity. However, the addition of imaging sequences used to visualize these biomarkers (Time of Acquisition, TA: ~6 minutes) increases the overall patient scan time. This study addresses this by combining parallel imaging (TA: ~2 minutes) with our proposed deep learning-based image denoising method, complex-valued denoising convolutional neural network (ℂDnCNN), to generate high quality data. Network layers used in the denoising convolutional neural network (DnCNN) were extended to the complex domain for learning complex-valued MR image features in the image domain. Four real-valued and complex-valued versions of this network (2D DnCNN, 2D ℂDnCNN, 3D DnCNN, and 3D ℂDnCNN) were developed for testing on a simulated noise testing set and a real-world noise testing set. In the simulated noise testing set, 3D ℂ DnCNN outperformed the other approaches for denoising magnitude and complex MRI data across all levels of simulated noise. In the real-world noise testing set, 2D DnCNN yielded the highest increases for NRMSE, PSNR and CNR measures, while 3D DnCNN yielded the highest improvement for SSIM when denoising T2*-weighted magnitude images at the highest acceleration factor. For the complex-valued data, 3D ℂDnCNN outperformed 2D ℂDnCNN to produce high quality magnitude and phase data at all acceleration factors in all image quality metrics except for CNR measures. Overall, our study demonstrates the capability of deep learning-based image denoising methods to efficiently denoise ultra-fast submillimeter isotropic data. Our proposed ℂDnCNN is able to denoise complex-valued MRI data which further enables the generation of high-quality quantitative susceptibility mapping (QSM). Besides that, our experimental results using different denoising models indicate that CNNs should be designed to learn 3-dimensional image features in the complex domain to achieve optimal performance on MRI data.

Indexed as

Convolutional neural networksImage denoisingImaging biomarkersMagnetic Resonance ImagingMultiple sclerosisSusceptibility weighted imaging

Identifiers

PMID42453704
PMCPMC13367514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.